Drugs / BI 1387446
last change Mar 2024 re-read 2 minutes ago

BI 1387446

Developed for
neoplasm
Investigated by
Boehringer Ingelheim

Trials 1 · a red edge is where a trial was stopped

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04147234 Aug 2020 → Nov 2022 neoplasm Boehringer Ingelheim Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BI 1387446 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04147234